Citations as recorded by:

1. New advances of TMEM88 in cancer initiation and progression, with special emphasis on Wnt signaling pathway

J Cell Physiol, 2018, 233(1) p. 79

DOI: 10.1002/jcp.25853

Citations as recorded by: Cross Ref Google

2. Fluorescence resonance energy transfer usage to track the sequence promoter changes in CGB5 gene in ovarian cancer patients

Biomedicine & Pharmacotherapy, 2017, 90 p. 139

DOI: 10.1016/j.biopha.2017.02.113

Citations as recorded by: Cross Ref

3. Fluorescence resonance energy transfer usage to track the sequence promoter changes in CGB5 gene in ovarian cancer patients.

Biomed. Pharmacother., 2017, 90 p. 1

DOI: S0753-3322(17)30013-6

Citations as recorded by: Google

4. MicroRNAs in Gynecological Cancers: Small molecules with big implications

Cancer Lett, 2017, 407 p. 123

DOI: 10.1016/j.canlet.2017.05.011

Citations as recorded by: Google

5. microRNA 在浆液性卵巢癌中的研究进展

Year: 2017

Citations as recorded by: Google

6. MicroRNAs are key regulators of hepatocellular carcinoma (HCC) cell dissemination—what we learned from microRNA-494

Hepatobiliary Surg Nutr, 2016, 5 p. 372

DOI: 10.21037/hbsn.2016.05.07

Citations as recorded by: PMC Google

7. CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494

Biochemical and Biophysical Research Communications, 2016, 480(4) p. 675

DOI: 10.1016/j.bbrc.2016.10.114

Citations as recorded by: Cross Ref Google

8. MicroRNA-based screens for synthetic lethal interactions with c-Myc

RNA Dis, 2016, 3

DOI: 10.14800/rd.1330

Citations as recorded by: PMC Google

9. Lysine-Specific Demethylase 1 (LSD1) Inhibitor S2101 Induces Autophagy via the AKT/mTOR Pathway in SKOV3 Ovarian Cancer Cells

Med Sci Monit, 2016, 22 p. 4742

DOI: 10.12659/MSM.898825

Citations as recorded by: Cross Ref PMC Google

10. miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2

Oncol Lett, 2016, 11 p. 4245

DOI: 10.3892/ol.2016.4527

Citations as recorded by: PMC Google

11. Importância dos fatores de Yamanaka e NANOG na resposta ao tratamento com cisplatina ou etoposídeo em células de terato carcinoma P19

Year: 2016

Citations as recorded by: Google